Close
Almac
Achema middle east

Boehringer Ingelheim BioXcellenceâ„¢ offers reliable world-class biopharmaceuticals contract manufacturing to the pharmaceutical and biotechnology industry.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma

Pfizer has confirmed that it has struck an almost...

€47mn as State Aid for New Aseptic Filling Plant from Vetter

The European Commission has stepped up and given the...
- Advertisement -

We offer a complete range of services, from cell line and strain development through process development and large-scale manufacturing to fill and finish. Our extensive portfolio of capabilities and technologies includes the production of antibodies, recombinant proteins, non-antibody scaffolds, Fab fragments as well as pDNA from either mammalian cell culture or microbial fermentation systems.

Over the past 35 years we have repeatedly converted promising product ideas into commercial reality on a global scale.

  • We are your alternative to risky capital investments for moving into production capacity.
  • We help you flexibly manage demand uncertainties.
  • We offer manufacturing excellence in a cost-effective way.
  • We give you the freedom to focus on your own strategic priorities.

 

Latest stories

Related stories

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma

Pfizer has confirmed that it has struck an almost...

€47mn as State Aid for New Aseptic Filling Plant from Vetter

The European Commission has stepped up and given the...

Eli Lilly to Invest over $6bn on the New Huntsville Facility

With an intent to make the incurable curable, Huntsville...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »